Methods and compositions for treating sleep apnea
The present invention relates to methods and compositions for treating sleep apnea. In general, the present invention relates to pharmaceutical compositions comprising (R)-oxybutynin and a noradrenaline reuptake inhibitor (NRI), and methods of treating sleep apnea comprising administering (R)-oxybut...
Saved in:
Main Authors | , , |
---|---|
Format | Patent |
Language | Chinese English |
Published |
26.07.2024
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | The present invention relates to methods and compositions for treating sleep apnea. In general, the present invention relates to pharmaceutical compositions comprising (R)-oxybutynin and a noradrenaline reuptake inhibitor (NRI), and methods of treating sleep apnea comprising administering (R)-oxybutynin and a noradrenaline reuptake inhibitor (NRI). In some embodiments, the NRI is atomoxetine.
本发明涉及用于治疗睡眠呼吸暂停的方法和组合物。总的来说,本发明涉及包括(R)-奥昔布宁和去甲肾上腺素再摄取抑制剂(NRI)的药物组合物,和包括给予(R)-奥昔布宁和去甲肾上腺素再摄取抑制剂(NRI)的治疗睡眠呼吸暂停的方法。在一些实施方案中,NRI为托莫西汀。 |
---|---|
Bibliography: | Application Number: CN202410467832 |